TY  - GEN
AU  - De Stefano,N
AU  - Filippi,M
AU  - Confavreux,C
AU  - Vermersch,P
AU  - Simu,M
AU  - Sindic,C
AU  - Hupperts,R
AU  - Bajenaru,O
AU  - Edan,G
AU  - Grimaldi,L
AU  - Marginean,I
AU  - Medaer,R
AU  - Orefice,G
AU  - Pascu,I
AU  - Pelletier,J
AU  - Sanders,E
AU  - Scarpini,E
AU  - Mancardi,G L
TI  - The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis
SN  - 1352-4585
PY  - 2009///0413
KW  - Adult
KW  - Chemistry, Pharmaceutical
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Glatiramer Acetate
KW  - Humans
KW  - Immunosuppressive Agents
KW  - administration & dosage
KW  - Injections, Subcutaneous
KW  - Male
KW  - Molecular Weight
KW  - Multiple Sclerosis, Relapsing-Remitting
KW  - drug therapy
KW  - Peptides
KW  - Pilot Projects
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1177/1352458508098269
ER  -